Scalar field Clause Samples

Scalar field. ‌ I now investigate the effects that the inverse-volume and holonomy corrections can have when I couple gravity to an undeformed scalar field. In this case, the energy and pressure densities are given by ρ = φ˙ 2 2 + U (φ), P = φ˙ 2 − U (φ), (4.48) and the continuity equation gives us the equation of motion for the scalar field, φ¨ + 3Hφ˙ + U′ = 0, (4.49) where U′ = ∂U . Let us investigate the era of slow-roll inflation. Using the assumptions |φ¨/U ′| ≪ 1 and 1 φ˙2 ≪ U , I have the slow-roll equations, φ˙ = −U′ , (4.50a) 3H 2 H = σ∅γ∅ U 3ω (1 − BI σ∅γ2 ♢˜ 3ω2 a2δ ∅ γ2 U ). (4.50b) If I substitute (4.50b) into (4.50a), take the derivative with respect to time and substitute in (4.50b) and (4.50a) again, I find where the slow-roll parameters are ▇▇ = ▇ ▇, (▇.▇▇) ▇ := 1 ( ω U′′ − (1 − 2ς)ϵ + χ − δς) , (4.52a) 1 − ς γ∅ U 1 − ς 2γ∅ ( U′ )2 χ := 1 − 3ς ∂ log γ∅ BI ∅ 2 ∂ log a γ2 ♢˜ 3ω2 a2δ γ2 U, (4.52d) and the conditions for slow-roll inflation are

Related to Scalar field

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.